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Abstract 23 
Background: The loss of muscle mass and strength that occurs with aging, termed sarcopenia, has been 24 
(at least partly) attributed to an impaired muscle protein synthetic response to food intake. We previously 25 
showed that neuromuscular electrical stimulation (NMES) can stimulate fasting muscle protein synthesis 26 
rates and prevent muscle atrophy during disuse. We hypothesized that NMES prior to protein ingestion 27 
would increase postprandial muscle protein accretion. 28 
Methods: Eighteen healthy, elderly (69±1 y) males participated in this study. After performing a 70 min 29 
unilateral NMES protocol, subjects ingested 20 g intrinsically L-[1-13C]-phenylalanine-labeled casein. 30 
Plasma samples and muscle biopsies were collected to assess postprandial mixed muscle and myofibrillar 31 
protein accretion, as well as associated myocellular signaling, during a 4 hour postprandial period in both 32 
the control (CON) and stimulated (NMES) leg. 33 
Results: Protein ingestion resulted in rapid increases in both plasma phenylalanine concentrations and L-34 
[1-13C]-phenylalanine enrichments, which remained elevated during the entire 4 h postprandial period 35 
(P<0.05). Mixed muscle protein bound L-[1-13C]-phenylalanine enrichments significantly increased over 36 
time following protein ingestion, with no differences between the CON (0.0164±0.0019 MPE) and NMES 37 
(0.0164±0.0019 MPE) leg (P>0.05). In agreement, no differences were observed in the postprandial rise 38 
in myofibrillar protein bound L-[1-13C]-phenylalanine enrichments between the CON and NMES legs 39 
(0.0115±0.0014 vs 0.0133±0.0013 MPE, respectively; P>0.05). Significant increases in mTOR and 40 
P70S6K phosphorylation status were observed in the NMES stimulated leg only (P<0.05). 41 
Conclusion: A single session of NMES prior to food intake does not augment postprandial muscle 42 
protein accretion in healthy, older men. 43 
 44 
Abstract word count: 247  45 
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Introduction 46 
Aging is accompanied by declines in skeletal muscle mass and strength, termed sarcopenia (24). A less 47 
than optimal diet and sedentary lifestyle are factors contributing to sarcopenia (24, 30). However, the 48 
underlying mechanisms remain to be elucidated. From a physiological perspective, any loss of muscle 49 
mass must be attributed to an imbalance between muscle protein synthesis and breakdown rates. Research 50 
has generally demonstrated that basal (i.e. postabsorptive) muscle protein synthesis (8, 18, 36, 41) and 51 
breakdown (37, 48) rates do not change with advancing age. As such, research has since focused on the 52 
impact of aging on the anabolic response to food intake. Recent work has shown that the skeletal muscle 53 
protein synthetic response to dietary protein ingestion is impaired in older individuals (8, 20, 41). This 54 
‘anabolic resistance’ to food intake is now regarded as a key factor in the etiology of sarcopenia (26, 41). 55 
Accordingly, we (18, 23, 42) and many others (8, 25, 29, 32) have begun to investigate ways to overcome 56 
anabolic resistance in older individuals in an effort to develop more effective strategies to attenuate age-57 
related muscle loss and support healthy aging. 58 
One strategy that has been shown to be effective to increase the postprandial muscle protein synthetic 59 
response to feeding is physical activity performed prior to food ingestion (6, 28, 34, 49, 50). By 60 
combining the ingestion of a meal-like bolus (i.e. 20 g) of intrinsically-labelled milk protein with the 61 
continuous infusion of stable isotope-labelled amino acids, we were able to show that a single bout of 62 
physical activity performed prior to protein ingestion increases postprandial muscle protein synthesis 63 
rates, with more of the dietary protein derived amino acids being used as precursors for de novo muscle 64 
protein accretion (28). However, some conditions do not allow an increase in physical activity level. For 65 
example, acute periods of illness or injury necessitate short periods of bed rest or limb immobilization. 66 
Such successive short periods of local or whole-body muscle disuse increase anabolic resistance to 67 
feeding and contribute to the development of sarcopenia during the lifespan (21, 39). Therefore, 68 
alternative strategies to maximize the postprandial muscle protein synthetic response to food ingestion are 69 
warranted in both health and disease. 70 
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In situations where physical activity levels are reduced, neuromuscular electrical stimulation (NMES) 71 
may be used as an alternative means to elicit muscle contraction. We have previously shown that NMES 72 
increases (fasting) muscle protein synthesis rates (40), and can be applied effectively to prevent muscle 73 
atrophy during short periods of muscle disuse in young men (11) as well as critically ill patients (9). In 74 
the present study, we hypothesized that a single bout of NMES improves postprandial protein accretion 75 
by increasing the postprandial use of dietary protein derived amino acids for de novo muscle protein 76 
synthesis in older adults. To test this hypothesis, we selected 18 healthy older males who were subjected 77 
to 70 min of unilateral NMES followed by the ingestion of 20 g intrinsically L-[1-13C]-phenylalanine-78 
labelled casein protein. This was combined with regular blood and muscle tissue sampling to assess 79 
postprandial protein accretion and underlying myocellular signaling in both the stimulated and non-80 
stimulated leg.  81 
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Methods 82 
 83 
Subjects 84 
Eighteen healthy, elderly men (age 69±1 y) were selected to participate in the present study. Subjects 85 
were excluded if one of the following criteria were met: BMI below 18.5 or above 30 kg·m-2, type 2 86 
diabetes mellitus, use of non-steroidal anti-inflammatory drugs, presence of a pacemaker or implantable 87 
cardioverter defibrillator, or having participated in any regular resistance-type exercise program within 6 88 
months prior to the study. Subjects’ characteristics are displayed in Table 1. All subjects were informed 89 
on the nature and risks of the study before written informed consent was obtained. The study was 90 
approved by the Medical Ethical Committee of the Maastricht University Medical Centre+ in accordance 91 
with the Declaration of Helsinki. 92 
 93 
Pretesting 94 
All subjects filled out a health questionnaire and completed a routine medical screening before inclusion 95 
into the study. During this visit, an Oral Glucose Tolerance Test (OGTT) was performed in a fasted state 96 
(2) to test for type 2 diabetes mellitus, and height and weight were measured. A second visit was 97 
performed to assess body composition via whole-body dual energy x-ray absorptiometry (DEXA) and 98 
single-slice computed tomography (CT) of m. quadriceps femoris, at 15 cm above the patella. Also during 99 
this visit, subjects were familiarized with the NMES protocol to be used in the experimental visit (see 100 
below for details). 101 
 102 
Diet and physical activity prior to testing 103 
The evening prior to the test day, subjects consumed a standardized meal containing 2900 kJ providing 51 104 
energy% (en%) as carbohydrate, 32 en% as fat, and 17 en% as protein. All subjects received instructions 105 
to refrain from any sort of heavy physical activity and to keep their diet as constant as possible during the 106 
48 h prior to the test day.  107 
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 108 
Experimental protocol 109 
An overview of the experimental protocol is depicted in Figure 1. After an overnight fast, subjects 110 
arrived at the laboratory at 8:00 AM for a single test day. While resting in a supine position on a bed, a 111 
catheter was placed in a heated dorsal hand vein and placed in a hot box at 60ºC for arterialized venous 112 
blood sampling (1). After collection of a basal arterialized blood sample at t = -210 min, a blood sample 113 
was collected 120 min (t = -90 min) after the baseline sample. After this, an NMES protocol (see below 114 
for details) was started at t = -70 min. After terminating the NMES session at t = 0 min, a blood sample 115 
was taken, and muscle biopsies were collected from both the stimulated (NMES) and the non-stimulated 116 
(CON) leg within approximately 5 min after the end of the NMES protocol. Subjects then received a test 117 
drink containing 20 g intrinsically L-[1-13C]-phenylalanine-labeled protein. The consumption of this drink 118 
signified the beginning of a 4 h postprandial period. Arterialized blood samples were subsequently 119 
collected every 60 min with the final sample being taken at t = 240 min. At the same time (at t = 240 120 
min), muscle biopsy samples were taken from both the NMES and CON leg. 121 
Arterialized venous blood samples were collected into pre-cooled EDTA-containing tubes and 122 
centrifuged at 1000g for 10 min at 4ºC. Aliquots of plasma were snap frozen in liquid nitrogen and stored 123 
at -80ºC until further analysis. Muscle biopsy samples were collected from the middle region of m. vastus 124 
lateralis, ~15 cm above the patella (4). Any visible non-muscle tissue was removed, and the muscle 125 
sample was frozen in liquid nitrogen. Subsequently, samples were stored at -80ºC until further analysis. 126 
 127 
Neuromuscular electrical stimulation 128 
After inclusion, one of the subjects’ legs was randomly allocated to receive 70 min of NMES during the 129 
experimental visit. Prior to the NMES session, subjects were placed in a supine position with a pillow 130 
underneath both knees to instigate light knee flexion. Four self-adhesive electrodes (50 x 50 mm; Enraf-131 
Nonius, Rotterdam, the Netherlands) were placed on the distal part at the muscle belly of the m. rectus 132 
femoris and the m. vastus lateralis, and at the inguinal area of both muscles of both legs. The electrodes 133 
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were connected to an Enraf-Nonius TensMed S84 stimulation device, discharging biphasic symmetric 134 
rectangular-wave pulses. However, NMES was only applied to one leg (NMES) while the other leg 135 
served as a sham-treated control (CON). The 70-min protocol consisted of a warm-up phase (5 min, 5 Hz, 136 
250 μs), a stimulation period (60 min, 100 Hz, 400 μs, 5 s on (0.75 s rise, 3.5 s contraction, 0.75 s fall) 137 
and 10 s off), and a cooling-down phase (5 min, 5 Hz, 250 μs). This protocol was selected as we 138 
previously demonstrated it is effective in preventing muscle atrophy during short-term disuse in young 139 
men (11) and critically ill patients (9). Subjects were encouraged to continuously adjust the intensity of 140 
the stimulation to the level where a full contraction of m. quadriceps femoris was both visible and 141 
palpable, with the heel slightly being lifted from the bed. The NMES protocol was completed by all 142 
subjects. The maximal intensity of the 70 min NMES session averaged 35.9±2.7 mA, whereas the average 143 
intensity across all subjects and sessions averaged 26.1±1.5 mA. 144 
 145 
Preparation of intrinsically labeled protein 146 
Intrinsically L-[1-13C]-phenylalanine-labeled micellar casein protein was obtained by infusing a Holstein 147 
cow with large quantities of L-[1-13C]-phenylalanine, collecting milk, and purifying the casein fraction as 148 
described previously (35). The average L-[1-13C]-phenylalanine enrichment was 38.7 mole percent excess 149 
(MPE). All subjects received a drink with 20 g casein in a total volume of 350 mL, flavored with vanilla 150 
flavor. 151 
 152 
Plasma analyses 153 
Plasma glucose and insulin concentrations were analyzed by Dr. Stein und Kollegen Laboratories 154 
(Mönchengladbach, Germany) using commercially available kits (GLUC3, Roche, Ref: 05168791 190, 155 
and Immunologic, Roche, Ref: 12017547 122, respectively). Plasma amino acid concentrations and 156 
enrichments were determined by GC-MS (Agilent 7890A GC/5975C; MSD, Little Falls, DE, USA). 157 
Plasma phenylalanine was converted to its tert-butyl dimethylsilyl (TBDMS) derivative before analysis 158 
by GC-MS by using electron impact ionization by monitoring ions at mass/charge (m/z) 336 and 337 for 159 
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unlabeled and [1-13C]-labeled phenylalanine, respectively (42). Standard regression curves were applied 160 
from a series of known standard enrichment values against the measured values to assess the linearity of 161 
the mass spectrometer and to account for any isotope fractionation which may have occurred during the 162 
analysis. Phenylalanine enrichments were corrected for the presence of the 13C isotopes. 163 
 164 
Muscle tissue analyses 165 
Mixed muscle protein bound enrichments were determined in a piece of wet muscle (~45 mg) as 166 
described previously (18). Briefly, muscle was freeze-dried, and collagen, blood and other visible non-167 
muscle material was removed under a dissecting microscope. After homogenizing and incubating samples 168 
in ice-cold 2% perchloric acid (PCA), samples were centrifuged. The supernatant was collected for 169 
determination of L-[1-13C]-phenylalanine enrichments in the muscle free amino acid pool using GC-MS 170 
analysis (42). The mixed muscle protein pellet washed, hydrolyzed overnight, and dried under a nitrogen 171 
stream. Next, free amino acids were dissolved in 50% acetic acid solution and passed over cation 172 
exchange AG 50W0X8 resin columns. To determine the L-[1-13C]-phenylalanine enrichment, the purified 173 
amino acids were derivatized into their N(O,S)-ethoxycarbonyl ethyl ester derivatives with ethyl 174 
chloroformate (ECF), and then measured by GC-C-IRMS (MAT 253; Thermo Scientific, Bremen, 175 
Germany) using a DB5-MS-column (no. 122122-5532; Agilent J+W, USA), GC Isolink, and monitoring 176 
ion masses 44, 45, and 46. By establishing the relation between the enrichment of a series of L-[1-13C]-177 
phenylalanine standards of variable enrichments and the enrichments of the N(O,S)-ethoxycarbonyl ethyl 178 
esters of these standards, the mixed muscle protein-bound enrichment of phenylalanine was determined. 179 
Myofibrillar protein enriched fractions were extracted from wet muscle tissue as described elsewhere (5). 180 
In short, ~50 mg wet muscle tissue was manually homogenized on ice using a Teflon pestle in a standard 181 
extraction buffer, after which the samples were centrifuged and the supernatants containing sarcoplasmic 182 
proteins were removed. In an additional step, the myofibrillar fraction-containing supernatant was 183 
collected and the collagen pellet was removed. The remaining myofibrillar fraction was purified and 184 
hydrolyzed, such that the free amino acids remained and could be dried under a nitrogen stream. The 185 
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enrichment of the derivative was measured by GC-C-IRMS by using a DB5-MS-column (no. 122-5532; 186 
Agilent J+W, USA), GC Isolink, and monitoring of ion masses 44, 45, and 46. By establishing the 187 
relationship between the enrichment of a series of L-[1-13C]-phenylalanine standards of variable 188 
enrichment, the myofibrillar protein-bound enrichment of phenylalanine was determined. Standard 189 
regression curves were applied to assess the linearity of the mass spectrometer and to control for the loss 190 
of tracer. Muscle protein deposition from the ingested casein over the 4 h postprandial period was 191 
expressed as the relative increase of L-[1-13C]-phenylalanine enrichment in muscle tissue. 192 
Western blot analyses were performed as described previously (9). In short, ~30 mg muscle tissue was 193 
homogenized and protein quantification was performed. After protein quantification, the gels were 194 
transferred onto a nitrocellulose membrane. Specific proteins were detected by overnight incubation with 195 
the following antibodies: anti-mTOR (289 kDa; dilution 1:1000, #2972 Cell Signaling, Danvers, MA, 196 
USA) and anti-phospho-mTOR (Ser2448; 289 kDa, dilution 1:1000, #2971 Cell Signaling), anti-P70S6K 197 
(70 kDa; dilution 1:1000, #9202 Cell Signaling) and anti-phospho P70S6K (Thr389; 70 kDa, dilution 198 
1:1000, #9206 Cell Signaling), anti-RS6 (32 kDa; dilution 1:1000; #2217 Cell Signaling) and anti-199 
phospho-RS6 (Ser235/Ser236, 32 kDa; dilution 1:1000; #4856 Cell Signaling) and anti α-tubulin (52 kDa; 200 
dilution 1:1000; #2125 Cell Signaling). The complementary secondary antibodies applied were IRDye 201 
680 donkey anti-rabbit (Cat. No. 926-32223, dilution 1:10000, Li-Cor, Lincoln, NE, USA) and IRDye 202 
800CW donkey anti-mouse (Cat. No. 926-32212, dilution 1:10000, Li-Cor). Protein quantification was 203 
performed by scanning on an Odyssey Infrared Imaging System (LI-COR Biotechnology, Lincoln, NE, 204 
USA). 205 
 206 
Statistics 207 
All data are expressed as means±SEM. Differences in baseline leg values (i.e. left vs right) were 208 
determined using a paired samples t-test. A one-way repeated measures analysis of variance (ANOVA) 209 
with time as within-subjects factor was used to analyze effects in plasma concentrations and enrichments. 210 
Differences in protein-bound L-[1-13C]-phenylalanine enrichments between legs after 4 h incorporation 211 
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were analyzed using a paired-samples t-test. When a significant main effect was detected, Bonferroni’s 212 
post hoc test was applied to locate the differences. Statistical analyses were performed using the SPSS 213 
version 22.0 software package (SPSS Inc., Chicago, IL, USA), with statistical significance set at P<0.05.214 
11 
 
Results 215 
 216 
Plasma analyses 217 
For plasma glucose and insulin concentrations, depicted in Figure 2, a significant time effect was 218 
observed (both P<0.001). During the postprandial period, plasma glucose and insulin concentrations 219 
averaged 5.6±0.1 mmol·L-1 and 7.5±0.8 mU·L-1, respectively. Figure 3 displays plasma concentrations of 220 
phenylalanine (A), tyrosine (B), and leucine (C). At the start of the experiment, fasting plasma 221 
phenylalanine, tyrosine, and leucine concentrations averaged 54±1, 62±2 and 128±5 μM, respectively. 222 
Following the ingestion of 20 g casein, at t = 0 min, concentrations of these three amino acids increased 223 
rapidly (time effect; P<0.001) and remained elevated until the end of the experiment. Figure 4 depicts 224 
plasma enrichments of L-[1-13C]-phenylalanine. After ingestion of the protein beverage, plasma L-[1-225 
13C]-phenylalanine enrichments increased (P<0.001), and remained elevated throughout the 4 h 226 
postprandial period. 227 
 228 
Muscle tracer analyses 229 
Muscle free L-[1-13C]-phenylalanine enrichments averaged 4.1±0.2 and 4.1±0.2 MPE at 4 h after protein 230 
ingestion in the CON and NMES leg, respectively, which did not differ (P>0.05). Figure 5A depicts 231 
mixed muscle L-[1-13C]-phenylalanine enrichments following ingestion of 20 g casein in the CON and 232 
NMES leg. Four hours after the ingestion of 20 g casein protein, mixed muscle L-[1-13C]-phenylalanine 233 
enrichments did not differ between legs: 0.0164±0.0019 and 0.0164±0.0019 MPE in the CON and NMES 234 
leg, respectively (P>0.05). L-[1-13C]-phenylalanine enrichments of the intracellular free amino acid pool 235 
were 4.074±0.183 and 4.115±0.163 MPE in the CON and NMES leg, respectively (P>0.05). 236 
Myofibrillar protein bound L-[1-13C]-phenylalanine enrichments are presented in Figure 5B. Ingestion of 237 
20 g casein resulted in an increase in L-[1-13C]-phenylalanine enrichments up to 0.0115±0.0014 and 238 
0.0133±0.0013 MPE in the CON and NMES leg, respectively (P>0.05).  239 
 240 
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Signaling proteins 241 
The muscle phosphorylation status of selected proteins involved in the regulation of muscle protein 242 
synthesis is displayed in Figure 6. Data are expressed as the ratios between the phosphorylated protein 243 
and the total protein content. Directly after cessation of the NMES, for P70S6K, a higher phosphorylation 244 
status was observed in the NMES leg when compared to the CON leg (P<0.05, Figure 6B). Following 245 
protein ingestion, the phosphorylation status of mTOR (Figure 6A) significantly increased over time in 246 
the NMES leg only (interaction effect; P<0.05). No changes in the phosphorylation status of P70S6K 247 
were observed after protein ingestion between legs or over time. Despite a significant interaction effect 248 
for RS6 (Figure 6C; P<0.01), no changes over time were found in the CON and NMES legs. 249 
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Discussion 250 
In the present study we show that neuromuscular electrical stimulation (NMES) prior to protein ingestion 251 
does not augment the use of dietary protein derived amino acids for de novo muscle protein accretion in 252 
healthy, older males. Nevertheless, we observed significant increases in mTOR and P70S6K 253 
phosphorylation in muscle following the bout of NMES. 254 
Aging is accompanied by declines in skeletal muscle mass and strength, called sarcopenia (24). Previous 255 
research has shown that the older population possesses a blunted skeletal muscle protein synthetic 256 
response to food intake, termed ‘anabolic resistance’ (8, 20, 41). This anabolic resistance is now believed 257 
to represent a key factor in the etiology of sarcopenia (26, 41). In the current study, intake of a meal-like 258 
amount of 20 g intrinsically-labeled casein led to a rapid increase in both plasma insulin (Figure 2) and 259 
amino acid concentrations (Figure 3), which was accompanied by an increase in plasma L-[1-13C]-260 
phenylalanine enrichment that remained elevated for the entire 4 h postprandial period (Figure 4). Taken 261 
together, all prerequisites were provided for an increase in anabolic signaling with ample amino acids 262 
made available as precursors to support postprandial muscle protein accretion. Indeed, these dietary 263 
protein derived amino acids were rapidly used for de novo muscle protein synthesis, as evidenced by the 264 
~0.016 MPE increase in muscle protein bound L-[1-13C]-phenylalanine in mixed muscle tissue and 265 
~0.012 MPE in the myofibrillar fraction of the muscle tissue obtained in the control leg 4 h after protein 266 
ingestion (Figure 5). The use of intrinsically L-[1-13C]-phenylalanine labeled protein allows us to assess 267 
the percentage of the ingested protein that was released into the circulation and used for de novo muscle 268 
protein synthesis (19). Based on the assumption that L-[1-13C]-phenylalanine enrichments in m. vastus 269 
lateralis would be representative of most other muscle groups, we calculated that a total of 0.037±0.004 g 270 
L-[1-13C]-phenylalanine had been incorporated in all appendicular lean tissue during the entire 4 h 271 
postprandial period. This translates to 2.0±0.2 g muscle protein, and equals 9.9±1.2% of the ingested 272 
dietary protein derived amino acids that were incorporated in de novo muscle protein. These data are in 273 
line with our recent calculations (19) and demonstrate the possibilities of using intrinsically labeled 274 
protein to demonstrate the metabolic fate of dietary protein derived amino acid in vivo in humans (35). 275 
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Physical activity performed prior to food intake has been shown to further increase postprandial muscle 276 
protein synthesis compared with food intake alone (6, 28, 34, 49, 50), and to augment the use of protein 277 
derived amino acids for de novo muscle protein synthesis (28). Currently, it remains unknown to what 278 
extent the stimulating properties of physical activity are attributed to its impact on skeletal muscle 279 
perfusion or whether the effects are predominantly intramuscular. As maintaining or increasing physical 280 
activity can be compromised in various clinical and non-clinical settings, exercise mimetics such as 281 
NMES may be used to evoke involuntary contractions to reintroduce some level of physical activity. 282 
Indeed, previous work from our group has shown that local NMES can increase post-absorptive muscle 283 
protein synthesis rates by as much as 27% when compared to the non-stimulated, control leg (40). To 284 
date, no studies have assessed the impact of NMES on the postprandial muscle protein synthetic response 285 
to feeding. In the current study, we assessed postprandial protein accretion following ingestion of a single 286 
bolus of intrinsically labelled protein in an electrically stimulated (NMES) and a non-stimulated, control 287 
leg. Despite the 70 min of neuromuscular electrical stimulation prior to protein ingestion we observed no 288 
differences in the muscle free [1-13C]-phenylalanine enrichments or the deposition of dietary protein 289 
derived amino acids into de novo muscle protein between both legs (0.0164±0.0019 vs 0.0164±0.0019 290 
MPE and 0.0115±0.0014 vs 0.0133±0.0013 MPE for the increase in [1-13C]-phenylalanine enrichment in 291 
mixed muscle protein and myofibrillar protein, respectively; Figure 5). Clearly, a single session of 292 
NMES prior to protein ingestion was not sufficient to modulate the metabolic fate of the dietary protein 293 
derived amino acids and did not augment postprandial protein deposition in the stimulated leg of these 294 
healthy, older males. In the current study, we employed a within-subjects design to eliminate between-295 
subject variability and isolate the local impact of NMES on muscle protein synthesis. It could be 296 
suggested that NMES may exert systemic effects that stimulate muscle protein synthesis in both the 297 
stimulated as well as the control leg (31, 51). However, previous work (46, 47) as well as the lack of 298 
differences in anabolic signaling between the CON and NMES leg (Figure 6) provide little evidence for 299 
such a ‘spillover’ effect during the early stages of recovery from NMES. 300 
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The postprandial stimulation of muscle protein synthesis is initiated by a phosphorylation cascade in 301 
which mammalian target of rapamycin (mTOR) and its downstream effectors P70S6 kinase (P70S6K) 302 
and ribosomal protein S6 (RS6) are key players (14, 22). This pathway is not only activated by protein 303 
intake, but also by physical activity (as reviewed in (45)). Here we show that protein ingestion did not 304 
lead to changes in activation of mTOR, P70S6K, and RS6 in the control leg (Figure 6). This is not 305 
surprising considering our low dose of protein administered (27) as well as previous work showing the 306 
peak of this translation initiation process to generally occur 1-2 h following protein ingestion, and to 307 
subside thereafter (7, 12, 17). Of course, the timing of our muscle biopsy collection that was chosen to 308 
optimally measure muscle protein-bound enrichments was likely not optimal for the detection of changes 309 
in anabolic signaling, which had probably subsided by then. However, we observed an early increase in 310 
the phosphorylation of P70S6K immediately following NMES (Figure 6). This is in agreement with our 311 
previous work demonstrating that an acute bout of NMES stimulates muscle protein synthesis in the 312 
postabsorptive state, possibly via a similar rise in P70S6K signaling (40), but is rather contradictory to 313 
previous studies showing an increase in P70S6K to occur only several hours after the cessation of 314 
exercise (7, 17). Previously, we have observed increases in P70S6K phosphorylation during or 315 
immediately after exercise without measurable increases in mTOR phosphorylation (3), which shows that 316 
activation of these pathways can occur early after the onset of exercise or electrostimulation before a 317 
measurable increase in mTOR activation. A significant increase in mTOR activation was not observed 318 
until 4 h after NMES (Figure 6). This is in line with previous data showing greater mTOR 319 
phosphorylation at 4 h after NMES (40) and 3 h postexercise (13) in older individuals. Clearly, the NMES 320 
did induce an anabolic stimulus, but this did not seem strong enough to augment the postprandial muscle 321 
protein synthetic response to feeding. 322 
Previously, we have shown that muscle loss during disuse can be prevented by the application of NMES 323 
in both young males during short-term immobilization (11) as well as in critically ill patients in a 324 
comatose state (9). This has been, at least partly, attributed to the increase in basal muscle protein 325 
synthesis rate that can be observed after performing a single session of NMES (40). In the present study, 326 
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we assessed whether NMES augmenting the muscle protein synthetic response to feeding may go some 327 
way to explaining the beneficial effect on muscle retention during disuse. In contrast to our hypothesis, 328 
we failed to detect a stimulatory effect of NMES on postprandial muscle protein accretion. This implies 329 
that NMES may particularly impact upon basal protein synthesis rates, as opposed to postprandial protein 330 
handling, in healthy older men. Although muscle disuse is associated with anabolic resistance to food 331 
intake (17, 38, 43), based on the present data it could be suggested that the observed efficacy of NMES to 332 
prevent disuse atrophy is primarily attained in the basal state (15, 16, 38). Though our results demonstrate 333 
that NMES does not affect postprandial protein handling in healthy, active individuals, we cannot exclude 334 
that NMES may modulate postprandial protein handling in a more clinically compromised state, where 335 
anabolic sensitivity to food intake is further reduced (12, 17, 38, 43) or in fact under situations where 336 
larger amounts, or more anabolic dietary proteins are provided to older subjects. Obviously, the efficacy 337 
of NMES combined with nutritional support may be of particular relevance for older hospitalized 338 
patients, who are losing muscle partially due to low dietary protein intake (10, 33, 44). Furthermore, it 339 
should be noted that we assessed the effect of a single bout of NMES only, and we cannot rule out any 340 
synergistic effects of multiple, repetitive NMES sessions performed over time. 341 
In conclusion, a single session of NMES prior to protein ingestion does not augment postprandial muscle 342 
protein accretion in healthy, older males. 343 
  344 
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Tables 517 
 518 
Table 1: Subjects’ characteristics 519 
Age (y) 69 ± 1 
Weight (kg) 83.4 ± 2.2 
BMI (kg·m-2) 26.5 ± 0.6 
Body fat (% body weight) 22.0 ± 1.0 
Lean body mass (kg) 62.5 ± 1.5  
Leg lean mass (kg) 10.0 ± 0.3 
Quadriceps CSA (mm2)* 7151 ± 266 
Leg volume (L) 8.4 ± 0.2 
Basal plasma glucose (mmol·L-1) 5.7 ± 0.1 
Basal plasma insulin (mU·L-1) 10.2 ± 1.0  
HbA1c (%) 5.4 ± 0.1 
OGIS (mL·min-1·m-2) 433 ± 9 
Values represent means±SEM. BMI, body mass index; CSA, cross-sectional area; HbA1c, glycosylated 520 
hemoglobin; OGIS, oral glucose insulin sensitivity. * Data from n=10 participants 521 
  522 
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Figure legends 523 
 524 
Figure 1: Outline of the experimental protocol. Eighteen healthy, older men ingested a protein drink 525 
containing 20 g casein following unilateral NMES (neuromuscular electrical stimulation). 526 
 527 
Figure 2: Means±SEM plasma glucose (A) and insulin (B) concentrations prior to and following 528 
ingestion of 20 g casein. The gray bar represents a 70 min NMES protocol. Data were analyzed with one-529 
way repeated measures ANOVA with time as within-subjects factor. A significant time effect (P<0.001) 530 
was found for both glucose and insulin. * Significantly different from t = 0 min (P<0.05).  531 
 532 
Figure 3: Mean±SEM plasma phenylalanine (A), tyrosine (B), and leucine (C) concentrations during the 533 
fasting period (t = -210 until 0 min) and following the ingestion of 20 g casein. The gray bar represents 534 
the 70 min NMES protocol. Data were analyzed with one-way repeated measures ANOVA with time as 535 
within-subjects factor. For all amino acids, significant time effects were observed (all P<0.001). * 536 
Significantly different from t = 0 min (P<0.05). 537 
 538 
Figure 4: Plasma [1-13C]-phenylalanine enrichments. The 70 min NMES protocol is visualized by the 539 
grey bar. Values are expressed as means±SEM. Data were analyzed with one-way repeated measures 540 
ANOVA with time as within-subjects factor. A significant time effect was found (P<0.001). * 541 
Significantly different from t = 0 min (P<0.05). 542 
 543 
Figure 5: Individual subjects’ mixed muscle (A) and myofibrillar protein-bound (B) L-[1-13C]-544 
phenylalanine enrichments (MPE) over a 4 h period following ingestion of 20 g casein, in the CON and 545 
NMES leg. Data are presented as means±SEM. 546 
 547 
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Figure 6: Skeletal muscle phosphorylation status (expressed as means±SEM) of selected proteins in the 548 
control (CON) and stimulated (NMES) leg. Muscle samples were taken directly after (t = 0 min) ingestion 549 
of 20 g casein protein, and 4 h thereafter (t = 240 min). * Significantly different from t = 0 min. # 550 
Significantly different from CON. Abbreviations: mTOR, mammalian target of rapamycin; P70S6K, 551 
P70S6 kinase; RS6, ribosomal protein S6. 552 
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